DAIC

JUNE 12, 2024

and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].

Stent 105

Stent Stents Anatomy Ultrasound 105

DAIC

MARCH 14, 2025

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

DAIC

MARCH 28, 2025

vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. a huge win: CMS significantly increases Medicare payments for cardiac CT. viii, ix, x, xi, xii, xiii, xiv, xv GE HealthCaredesigned Revolution Vibe to address these challenges. 2012) 380:2095128.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Becker's Hospital Review - Cardiology

DECEMBER 20, 2023

Cardiologists are speaking out against a Lown Institute report that alleged 1 in 5 stents placed in Medicare recipients were considered "overuse," Medscape reported Dec.

Stent 45

Stent Stents Medicare 45

DAIC

JUNE 18, 2024

1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. 2 “For many years, it was thought that caging of the vessel with stents was the main driver for annual increasing non-plateauing event rates. of the U.S. population. JACC 2020. 5 Saito S, et al.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

MARCH 20, 2024

The newly CE launched Freesolve RMS for coronary artery lesions, based on the BIOmag magnesium alloy and the proven Orsiro drug-eluting stent (DES) coating technology, provides safety, improved deliverability, and optimal performance and vessel support during and after implantation.2,3 2,3 It has shown 99.6%

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

American College of Cardiology

FEBRUARY 1, 2025

Initiatives such as the World Health Organization's "Medication Without Harm" and the Centers for Medicare and Medicaid Services' (CMS) expanded quality measures aim to reduce preventable emergency visits and hospital admissions due to medication-related harm.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40